drugset / Trial / NCT00157248
Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048
Non-randomizedOpen-labelPrevention
Summary
To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion, with or without concomitant chronic treatment with acetylsalicylic acid (ASA).
Timeline
- Start
- 2003-12
- Primary completion
- 2009-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 150 mg | — |
| Subject | Dabigatran etexilate | Unknown | 300 mg | — |